Protalix BioTherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hackensack, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 959 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 501-525 of 673 matching filings.

Per page
25
Current page
21
CT ORDER File 001-33357

CT ORDER filing

Filing date
18 Jul 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

8-K

Filing date
27 Jun 2014
Reporting date
27 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
18 Jun 2014
Reporting date
18 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
13 Jun 2014
Reporting date
13 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
30 May 2014
Reporting date
30 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
22 May 2014
Reporting date
22 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-50118

SC 13G

Filing date
12 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

SC 13G/A filing

Filing date
12 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
12 Feb 2014
Reporting date
12 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-50118

SC 13G filing

Filing date
28 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

CURRENT REPORT

Filing date
13 Jan 2014
Reporting date
13 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-33357

CT ORDER filing

Filing date
29 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
12 Nov 2013
Reporting date
07 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-33357

QUARTERLY REPORT

Filing date
07 Nov 2013
Reporting date
30 Sep 2013
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
15 Oct 2013
Reporting date
14 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-33357

AUTO-GENERATED PAPER DOCUMENT

Filing date
01 Oct 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33357

DEF 14A filing

Filing date
20 Sep 2013
Reporting date
07 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
18 Sep 2013
Reporting date
12 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
11 Sep 2013
Reporting date
11 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
03 Sep 2013
Reporting date
03 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
16 Aug 2013
Reporting date
14 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
20 Jun 2013
Reporting date
20 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .